The 2025 "Transtek Medical Open Day" Successfully Held

ZHONGSHAN, China - March 31, 2025 - PRLog -- To enhance public company sentiment management and investor relations while fostering media communication and industry collaboration, the Guangdong Listed Companies Association, in partnership with Securities Times, organized a special exchange event at Transtek Medical on March 18. The event brought together representatives from the Guangdong Listed Companies Association, Securities Times, Transtek Medical (300562.SZ), and 28 listed companies from Guangzhou, Zhongshan, and Zhuhai, totaling 45 participants.

Mr.David Pan, Chairman of Transtek Medical, and Ms. Huang Linxiang, Board Secretary and Chief Financial Officer, welcomed the attendees. During the event, participants toured Transtek Medical's Smart Health Exhibition Hall, gaining insights into the company's strategic positioning within the medical and healthcare industry and its latest achievements. Attendees were deeply impressed by the company's spirit of innovation.

During the conference, Mr.David Pan shared Transtek Medical's development history, industry layout, and strategic direction. He elaborated on the company's transformation and innovation efforts in recent years. Since initiating its business optimization strategy in 2022, Transtek Medical has undertaken strategic adjustments to its customer and product structures, prioritizing the refinement of high-margin and core business units while phasing out low-margin and asset-heavy operations. This transformation has yielded significant results. Ms. Huang Linxiang further introduced the company's innovative products and services, outlining Transtek Medical's expectations for future business development.

Looking ahead, Transtek Medical remains committed to advancing digital chronic disease management and driving innovation in smart healthcare. With technology innovation as its core engine and high-quality products and services as its foundation, the company strives toward its vision of becoming a global leader in remote health monitoring. Transtek Medical will continue to actively engage with the market, communicate its corporate value, and strengthen its brand presence.

Founded in 2000, Transtek is committed to multiple health fields such as remote health and chronic disease management, providing customers with medical-grade "RPM devices" and "cloud services". Transtek also provides one-stop connectivity technology, device management, and fulfillment services for Remote Patient Monitoring (RPM) providers. Transtek has established a co-branded solution named TeleRPM since 2019, it stands for Quality & Value which is the best of Transtek. TeleRPM is an integrated solution which includes cellular blood pressure monitor, cellular weight scale, cellular blood glucose meter and all-round BLE package with AnyHub solution. Also, TeleRPM is open and scalable, and Transtek will leverage their expertise to help customers realize greater value, potential and outcomes.